Live Breaking News & Updates on Phase 3 Alpine Trial

Stay updated with breaking news from Phase 3 alpine trial . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zanubrutinib Showcases Sustained PFS Benefit Vs Ibrutinib in R/R CLL/SLL

Zanubrutinib continued to demonstrate improved progression-free survival benefit over ibrutinib in the treatment of patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma, according to extended follow-up data from the phase 3 ALPINE trial. ....

United States , Dana Farber Cancer Institute , Zanubrutinib Brukinsa , Jenniferr Brown , Hematologic Malignancies , Margaret Collette Professor , Hematologic Oncology , Harvard Medical School , Chronic Lymphocytic Leukemia , Small Lymphocytic Leukemia , Phase 3 Alpine Trial , Ash Annual Meeting ,